CompoAtlas

Pure-le Natural Cedarwood Oil

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Cedrus atlantica

Source : Bois

1 Goutte(s)

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 yearsminimum: 1 Goutte(s) ; maximum: 12 Goutte(s)minimum: 1 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

Used in aromatherapy as a nervine/calmative. Used in aromatherapy to help relieve colds/cough.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Other names
Pure-le Organic Cedarwood Oil
Licence holder
Health4All Products Ltd.
NPN or DIN-HM
80094382
Status
Active licence
Licence date
12 September 2019
Revision date
Not provided
Form
Liquide
Route of administration
Inhalation
Application type
Officinale

Source

Official Health Canada record, licence 80094382

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Pure-le Natural Cedarwood Oil (Health4All Products Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80094382-pure-le-natural-cedarwood-oil, updated 12 September 2019.

Enter to analyse, Shift+Enter for a new line